Regulatory function of peroxiredoxin I on 4‑(methylnitrosamino)‑1‑(3‑pyridyl)‑1‑butanone‑induced lung cancer development (Review)
- Authors:
- Hu-Nan Sun
- Chen-Xi Ren
- Yi-Xi Gong
- Dan-Ping Xie
- Taeho Kwon
-
Affiliations: College of Life Science and Biotechnology, Heilongjiang Bayi Agricultural University, Daqing, Heilongjiang 163319, P.R. China, Primate Resources Center, Korea Research Institute of Bioscience and Biotechnology, Jeongeup, Jeonbuk 56216, Republic of Korea - Published online on: April 12, 2021 https://doi.org/10.3892/ol.2021.12726
- Article Number: 465
-
Copyright: © Sun et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Proctor RN: Tobacco and the global lung cancer epidemic. Nat Rev Cancer. 1:82–86. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Thun M, Peto R, Boreham J and Lopez AD: Stages of the cigarette epidemic on entering its second century. Tob Control. 21:96–101. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Witschi H: Carcinogenic activity of cigarette smoke gas phase and its modulation by beta-carotene and N-acetylcysteine. Toxicol Sci. 84:81–87. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Jin Z, Gao F, Flagg T and Deng X: Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone promotes functional cooperation of Bcl2 and c-Myc through phosphorylation in regulating cell survival and proliferation. J Biol Chem. 279:40209–40219. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Maser E: Significance of reductases in the detoxification of the tobacco-specific carcinogen NNK. Trends Pharmacol Sci. 25:235–237. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Yalcin E and de la Monte S: Tobacco nitrosamines as culprits in disease: Mechanisms reviewed. J Physiol Biochem. 72:107–120. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Yeh SL, Wang WY, Huang CS and Hu ML: Flavonoids suppresses the enhancing effect of beta-carotene on DNA damage induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A549 cells. Chem Biol Interact. 160:175–182. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Lehtonen ST, Svensk AM, Soini Y, Pääkkö P, Hirvikoski P, Kang SW, Säily M and Kinnula VL: Peroxiredoxins, a novel protein family in lung cancer. Int J Cancer. 111:514–521. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Gorrini C, Harris IS and Mak TW: Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 12:931–947. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Rhee SG and Kil IS: Multiple functions and regulation of mammalian peroxiredoxins. Annu Rev Biochem. 86:749–775. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Bajor M, Zych AO, Graczyk-Jarzynka A, Muchowicz A, Firczuk M, Trzeciak L, Gaj P, Domagala A, Siernicka M, Zagozdzon A, et al: Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents. Br J Cancer. 119:873–884. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Han YH, Zhang YQ, Jin MH, Jin YH, Qiu MY, Li WL, He C, Yu LY, Hyun JW, Lee J, et al: Peroxiredoxin I deficiency increases keratinocyte apoptosis in a skin tumor model via the ROS-p38 MAPK pathway. Biochem Biophys Res Commun. 529:635–641. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Hampton MB, Vick KA, Skoko JJ and Neumann CA: Peroxiredoxin involvement in the initiation and progression of human cancer. Antioxid Redox Signal. 28:591–608. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen MF, Chen WC, Wu CT, Lin PY, Shau H, Liao SK, Yang CT and Lee KD: p53 status is a major determinant of effects of decreasing peroxiredoxin I expression on tumor growth and response of lung cancer cells to treatment. Int J Radiat Oncol Biol Phys. 66:1461–1472. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Hirata N, Yamada S, Sekino Y and Kanda Y: Tobacco nitrosamine NNK increases ALDH-positive cells via ROS-Wnt signaling pathway in A549 human lung cancer cells. J Toxicol Sci. 42:193–204. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Shi GQ, Zhou WS, Li M, Ren F and Han YW: Characterization and expression analysis of peroxiredoxin genes in NNK-induced V79 cells. Biomed Environ Sci. 30:224–228. 2017.PubMed/NCBI | |
|
Immenschuh S and Baumgart-Vogt E: Peroxiredoxins, oxidative stress, and cell proliferation. Antioxid Redox Signal. 7:768–777. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Akopyan G and Bonavida B: Understanding tobacco smoke carcinogen NNK and lung tumorigenesis. Int J Oncol. 29:745–752. 2006.PubMed/NCBI | |
|
Hecht SS, Hochalter JB, Villalta PW and Murphy SE: 2′-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: Formation of a lung carcinogen precursor. Proc Natl Acad Sci USA. 97:12493–12497. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Peterson LA: Context matters: Contribution of specific DNA adducts to the genotoxic properties of the tobacco-specific nitrosamine NNK. Chem Res Toxicol. 30:420–433. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ashmore JH, Luo S, Watson CJW and Lazarus P: Carbonyl reduction of NNK by recombinant human lung enzymes: Identification of HSD17β12 as the reductase important in (R)-NNAL formation in human lung. Carcinogenesis. 39:1079–1088. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Leslie EM, Ghibellini G, Nezasa K and Brouwer KL: Biotransformation and transport of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in bile duct-cannulated wild-type and Mrp2/Abcc2-deficient (TR) Wistar rats. Carcinogenesis. 28:2650–2656. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Richter E, Friesenegger S, Engl J and Tricker AR: Use of precision-cut tissue slices in organ culture to study metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by hamster lung, liver and kidney. Toxicology. 144:83–91. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Rhee SG, Kang SW, Chang TS, Jeong W and Kim K: Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 52:35–41. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Neumann CA, Cao J and Manevich Y: Peroxiredoxin 1 and its role in cell signaling. Cell Cycle. 8:4072–4078. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Ding C, Fan X and Wu G: Peroxiredoxin 1-an antioxidant enzyme in cancer. J Cell Mol Med. 21:193–202. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Park YH, Kim SU, Lee BK, Kim HS, Song IS, Shin HJ, Han YH, Chang KT, Kim JM, Lee DS, et al: Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway. Antioxid Redox Signal. 19:482–496. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chang TS, Jeong W, Choi SY, Yu S, Kang SW and Rhee SG: Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation. J Biol Chem. 277:25370–25376. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Poole LB: The basics of thiols and cysteines in redox biology and chemistry. Free Radic Biol Med. 80:148–157. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Watanabe Y, Ishimori K and Uchida T: Dual role of the active-center cysteine in human peroxiredoxin 1: Peroxidase activity and heme binding. Biochem Biophys Res Commun. 483:930–935. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Gozzelino R, Jeney V and Soares MP: Mechanisms of cell protection by heme oxygenase-1. Annu Rev Pharmacol Toxicol. 50:323–354. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Guo Y, Patil NK, Luan L, Bohannon JK and Sherwood ER: The biology of natural killer cells during sepsis. Immunology. 153:190–202. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Aktaş ON, Öztürk AB, Erman B, Erus S, Tanju S and Dilege Ş: Role of natural killer cells in lung cancer. J Cancer Res Clin Oncol. 144:997–1003. 2018. View Article : Google Scholar | |
|
Li S, Wang R, Zhang M, Wang L and Cheng S: Proteomic analysis of non-small cell lung cancer tissue interstitial fluids. World J Surg Oncol. 11:1732013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen MF, Keng PC, Shau H, Wu CT, Hu YC, Liao SK and Chen WC: Inhibition of lung tumor growth and augmentation of radiosensitivity by decreasing peroxiredoxin I expression. Int J Radiat Oncol Biol Phys. 64:581–591. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Liu D, Mao P, Huang Y, Liu Y, Liu X, Pang X and Li Y: Proteomic analysis of lung tissue in a rat acute lung injury model: Identification of PRDX1 as a promoter of inflammation. Mediators Inflamm. 2014:4693582014. View Article : Google Scholar : PubMed/NCBI | |
|
Brenner DR, Fanidi A, Grankvist K, Muller DC, Brennan P, Manjer J, Byrnes G, Hodge A, Severi G, Giles GG, et al: Inflammatory cytokines and lung cancer risk in 3 prospective studies. Am J Epidemiol. 185:86–95. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
DeCotiis C, Hu Y, Greenberg AK, Huie M, Tsay JC, Pass H, Goldberg JD and Rom WN: Inflammatory cytokines and non-small cell lung cancer in a CT-scan screening cohort: Background review of the literature. Cancer Biomark. 16:219–233. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Chang JW, Lee SH, Jeong JY, Chae HZ, Kim YC, Park ZY and Yoo YJ: Peroxiredoxin-I is an autoimmunogenic tumor antigen in non-small cell lung cancer. FEBS Lett. 579:2873–2877. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Finkel T and Holbrook NJ: Oxidants, oxidative stress and the biology of ageing. Nature. 408:239–247. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Moloney JN and Cotter TG: ROS signalling in the biology of cancer. Semin Cell Dev Biol. 80:50–64. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Macip S, Igarashi M, Berggren P, Yu J, Lee SW and Aaronson SA: Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol. 23:8576–8585. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Moll HP, Pranz K, Musteanu M, Grabner B, Hruschka N, Mohrherr J, Aigner P, Stiedl P, Brcic L, Laszlo V, et al: Afatinib restrains K-RAS-driven lung tumorigenesis. Sci Transl Med. 10:eaao23012018. View Article : Google Scholar : PubMed/NCBI | |
|
Aran V and Omerovic J: Current approaches in NSCLC targeting K-RAS and EGFR. Int J Mol Sci. 20:57012019. View Article : Google Scholar : PubMed/NCBI | |
|
Scheffler M, Ihle MA, Hein R, Merkelbach-Bruse S, Scheel AH, Siemanowski J, Brägelmann J, Kron A, Abedpour N, Ueckeroth F, et al: K-ras mutation subtypes in NSCLC and associated Co-occuring mutations in other oncogenic pathways. J Thorac Oncol. 14:606–616. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Peeper DS, Upton TM, Ladha MH, Neuman E, Zalvide J, Bernards R, DeCaprio JA and Ewen ME: Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature. 386:177–181. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Slebos RJ, Kibbelaar RE, Dalesio O, Kooistra A, Stam J, Meijer CJ, Wagenaar SS, Vanderschueren RG, van Zandwijk N, Mooi WJ, et al: K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. N Engl J Med. 323:561–565. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Proulx LI, Paré G and Bissonnette EY: Alveolar macrophage cytotoxic activity is inhibited by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a carcinogenic component of cigarette smoke. Cancer Immunol Immunother. 56:831–838. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Rioux N and Castonguay A: The induction of cyclooxygenase-1 by a tobacco carcinogen in U937 human macrophages is correlated to the activation of NF-kappaB. Carcinogenesis. 21:1745–1751. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Narayanapillai SC, Hu Q, Fujioka N and Xing C: Detection and quantification of 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB) from smoker albumin and its potential as a surrogate biomarker of tobacco-specific nitrosamines exposure and bioactivation. Toxicol Lett. 311:11–16. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Peterson LA, Carmella SG and Hecht SS: Investigations of metabolic precursors to hemoglobin and DNA adducts of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 11:1329–1333. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Hecht SS, Stepanov I and Carmella SG: Exposure and metabolic activation biomarkers of carcinogenic tobacco-specific nitrosamines. Acc Chem Res. 49:106–114. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Hecht SS, Trushin N, Rigotty J, Carmella SG, Borukhova A, Akerkar S, Desai D, Amin S and Rivenson A: Inhibitory effects of 6-phenylhexyl isothiocyanate on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone metabolic activation and lung tumorigenesis in rats. Carcinogenesis. 17:2061–2067. 1996. View Article : Google Scholar : PubMed/NCBI | |
|
Tsiftsoglou AS, Tsamadou AI and Papadopoulou LC: Heme as key regulator of major mammalian cellular functions: Molecular, cellular, and pharmacological aspects. Pharmacol Ther. 111:327–345. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Severance S and Hamza I: Trafficking of heme and porphyrins in metazoa. Chem Rev. 109:4596–4616. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Shimizu T, Lengalova A, Martínek V and Martínková M: Heme: Emergent roles of heme in signal transduction, functional regulation and as catalytic centres. Chem Soc Rev. 48:5624–5657. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Khan AA and Quigley JG: Control of intracellular heme levels: Heme transporters and heme oxygenases. Biochim Biophys Acta. 1813:668–682. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Roumenina LT, Rayes J, Lacroix-Desmazes S and Dimitrov JD: Heme: Modulator of plasma systems in hemolytic diseases. Trends Mol Med. 22:200–213. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Vlasova II: Peroxidase activity of human hemoproteins: Keeping the fire under control. Molecules. 23:25612018. View Article : Google Scholar : PubMed/NCBI | |
|
Peralta IN, Cogoi L, Filip R and Anesini C: Prevention of hydrogen peroxide-induced red blood cells lysis by Ilex paraguariensis aqueous extract: Participation of phenolic and xanthine compounds. Phytother Res. 27:192–198. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Hahl P, Hunt R, Bjes ES, Skaff A, Keightley A and Smith A: Identification of oxidative modifications of hemopexin and their predicted physiological relevance. J Biol Chem. 292:13658–13671. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Therriault MJ, Proulx LI, Castonguay A and Bissonnette EY: Immunomodulatory effects of the tobacco-specific carcinogen, NNK, on alveolar macrophages. Clin Exp Immunol. 132:232–238. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Y and Cao X: The origin and function of tumor-associated macrophages. Cell Mol Immunol. 12:1–4. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Proulx LI, Castonguay A and Bissonnette EY: Cytokine production by alveolar macrophages is down regulated by the alpha-methylhydroxylation pathway of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK). Carcinogenesis. 25:997–1003. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Proulx LI, Gaudreault M, Turmel V, Augusto LA, Castonguay A and Bissonnette EY: 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone, a component of tobacco smoke, modulates mediator release from human bronchial and alveolar epithelial cells. Clin Exp Immunol. 140:46–53. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Mashimo M: Dual roles of α7 nicotinic acetylcholine receptors expressed in immune cells in T cell differentiation-α7 nAChRs exert different actions between antigen-presenting cells and CD4(+) T cells. Yakugaku Zasshi. 140:1421–1425. 2020.(In Japanese). View Article : Google Scholar : PubMed/NCBI | |
|
Schuller HM, Jull BA, Sheppard BJ and Plummer HK: Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: Potential role in lung carcinogenesis and pediatric lung disorders. Eur J Pharmacol. 393:265–277. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Rahim SS, Khan N, Boddupalli CS, Hasnain SE and Mukhopadhyay S: Interleukin-10 (IL-10) mediated suppression of IL-12 production in RAW 264.7 cells also involves c-rel transcription factor. Immunology. 114:313–321. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Zirnheld AL, Villard M, Harrison AM, Kosiewicz MM and Alard P: β-Catenin stabilization in NOD dendritic cells increases IL-12 production and subsequent induction of IFN-γ-producing T cells. J Leukoc Biol. 106:1349–1358. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chakraborty K, Zhou Z, Wakamatsu N and Guerrero-Plata A: Interleukin-12p40 modulates human metapneumovirus-induced pulmonary disease in an acute mouse model of infection. PLoS One. 7:e371732012. View Article : Google Scholar : PubMed/NCBI | |
|
Guo Y, Cao W and Zhu Y: Immunoregulatory functions of the IL-12 family of cytokines in antiviral systems. Viruses. 11:7722019. View Article : Google Scholar : PubMed/NCBI | |
|
Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 3:133–146. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Caligiuri MA: Human natural killer cells. Blood. 112:461–469. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Kinnula VL, Lehtonen S, Kaarteenaho-Wiik R, Lakari E, Pääkkö P, Kang SW, Rhee SG and Soini Y: Cell specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis. Thorax. 57:157–164. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Tae Lim Y, Sup Song D, Joon Won T, Lee YJ, Yoo JS, Eun Hyung K, Won Yoon J, Park SY and Woo Hwang K: Peroxiredoxin-1, a possible target in modulating inflammatory cytokine production in macrophage like cell line RAW264.7. Microbiol Immunol. 56:411–419. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Mennecier G, Torres LN, Cogliati B, Sanches DS, Mori CM, Latorre AO, Chaible LM, Mackowiak II, Nagamine MK, Da Silva TC, et al: Chronic exposure of lung alveolar epithelial type II cells to tobacco-specific carcinogen NNK results in malignant transformation: A new in vitro lung carcinogenesis model. Mol Carcinog. 53:392–402. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Vu T, Jin L and Datta PK: Effect of cigarette smoking on epithelial to mesenchymal transition (EMT) in lung cancer. J Clin Med. 5:442016. View Article : Google Scholar : PubMed/NCBI | |
|
Mehdi MZ, Pandey NR, Pandey SK and Srivastava AK: H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid Redox Signal. 7:1014–1020. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Shen J, Xu L, Owonikoko TK, Sun SY, Khuri FR, Curran WJ and Deng X: NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKCι/FAK loop. Cancer Lett. 318:106–113. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Liu H, Borok Z, Davies KJ, Ursini F and Forman HJ: Cigarette smoke extract stimulates epithelial-mesenchymal transition through Src activation. Free Radic Biol Med. 52:1437–1442. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Shintani Y, Okimura A, Sato K, Nakagiri T, Kadota Y, Inoue M, Sawabata N, Minami M, Ikeda N, Kawahara K, et al: Epithelial to mesenchymal transition is a determinant of sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann Thorac Surg. 92:1794–1804. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Tseng YC, Tsai YH, Tseng MJ, Hsu KW, Yang MC, Huang KH, Li AF, Chi CW, Hsieh RH, Ku HH and Yeh TS: Notch2-induced COX-2 expression enhancing gastric cancer progression. Mol Carcinog. 51:939–951. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Ocaña OH, Córcoles R, Fabra A, Moreno-Bueno G, Acloque H, Vega S, Barrallo-Gimeno A, Cano A and Nieto MA: Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell. 22:709–724. 2012. View Article : Google Scholar | |
|
Reichert M, Takano S, von Burstin J, Kim SB, Lee JS, Ihida-Stansbury K, Hahn C, Heeg S, Schneider G, Rhim AD, et al: The Prrx1 homeodomain transcription factor plays a central role in pancreatic regeneration and carcinogenesis. Genes Dev. 27:288–300. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Lee JM, Dedhar S, Kalluri R and Thompson EW: The epithelial-mesenchymal transition: New insights in signaling, development, and disease. J Cell Biol. 172:973–981. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ha B, Kim EK, Kim JH, Lee HN, Lee KO, Lee SY and Jang HH: Human peroxiredoxin 1 modulates TGF-β1-induced epithelial-mesenchymal transition through its peroxidase activity. Biochem Biophys Res Commun. 421:33–37. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Lamouille S and Derynck R: TGF-beta-induced epithelial to mesenchymal transition. Cell Res. 19:156–172. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yang Y, Pan X, Lei W, Wang J and Song J: Transforming growth factor-beta1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism. Oncogene. 25:7235–7244. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Derynck R and Akhurst RJ: Differentiation plasticity regulated by TGF-beta family proteins in development and disease. Nat Cell Biol. 9:1000–1004. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Gotzmann J, Huber H, Thallinger C, Wolschek M, Jansen B, Schulte-Hermann R, Beug H and Mikulits W: Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: Steps towards invasiveness. J Cell Sci. 115:1189–1202. 2002.PubMed/NCBI | |
|
Ushio-Fukai M and Nakamura Y: Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapy. Cancer Lett. 266:37–52. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA and Katz RL: Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res. 7:330–338. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Huang RY, Li MY, Hsin MK, Underwood MJ, Ma LT, Mok TS, Warner TD and Chen GG: 4-Methylnitrosamino- 1-3-pyridyl-1-butanone (NNK) promotes lung cancer cell survival by stimulating thromboxane A2 and its receptor. Oncogene. 30:106–116. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Hung YH and Hung WC: 4-(Methylnitrosamino)-1- (3-pyridyl)-1-butanone (NNK) enhances invasiveness of lung cancer cells by up-regulating contactin-1 via the alpha7 nicotinic acetylcholine receptor/ERK signaling pathway. Chem Biol Interact. 179:154–159. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Yan J, Wong N, Hung C, Chen WX and Tang D: Contactin-1 reduces E-cadherin expression via activating AKT in lung cancer. PLoS One. 8:e654632013. View Article : Google Scholar : PubMed/NCBI | |
|
Jin Z, Xin M and Deng X: Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-activated bad kinase. J Biol Chem. 280:16045–16052. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Wang KC, Liu YC, El-Shazly M, Shih SP, Du YC, Hsu YM, Lin HY, Chen YC, Wu YC, Yang SC and Lu MC: The antioxidant from ethanolic extract of Rosa cymosa fruits activates phosphatase and tensin homolog in vitro and in vivo: A new insight on its antileukemic effect. Int J Mol Sci. 20:19352019. View Article : Google Scholar : PubMed/NCBI | |
|
Neumann CA and Fang Q: Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol. 7:375–380. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Nauseef WM: Biological roles for the NOX family NADPH oxidases. J Biol Chem. 283:16961–16965. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Ge GZ, Xu TR and Chen C: Tobacco carcinogen NNK-induced lung cancer animal models and associated carcinogenic mechanisms. Acta Biochim Biophys Sin (Shanghai). 47:477–487. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hong WG, Kim JY, Cho JH, Hwang SG, Song JY, Lee E, Chang TS, Um HD and Park JK: AMRI-59 functions as a radiosensitizer via peroxiredoxin I-targeted ROS accumulation and apoptotic cell death induction. Oncotarget. 8:114050–114064. 2017. View Article : Google Scholar : PubMed/NCBI |
